WHO ICTRP trial
Gynecology Oncological clinical cooperation trial of Liposomal doxorubicin.
ChiCTR-ONC-13003650 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-ONC-13003650 |
|---|---|
| Public title | Gynecology Oncological clinical cooperation trial of Liposomal doxorubicin . |
| Scientific title | The study of comparison liposomal doxorubicin with topotecan for recurrent ovarian carcinoma after 6 months therapy of first-line platinum chemotherapy . |
| Primary sponsor | Shandong Tumor Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Post-market |
| Countries | China |
| Conditions | ovarian cancer |
| Interventions | Case series:Liposomal doxorubicin |
| Registration date | Sep 25, 2013 |
| Target size | Case series:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: